Grifols (GIKLY) Net Margin (2010 - 2019)
Grifols (GIKLY) posted Net Margin of 23.12% for Q1 2020, up 29.06% quarter-over-quarter from 17.91% in Q4 2019, and up 830.0% year-on-year from 2.49% in Q2 2019.
Grifols (GIKLY) Net Margin (2010 - 2019) Analysis & Trends
Grifols (GIKLY) has reported Net Margin for 10 consecutive years, with 23.12% the latest figure, recorded in Q1 2020.
- Net Margin for Q1 2020 came in at 23.12%, up 830.0% year-over-year; the trailing twelve-month figure through Mar 2020 was 11.94% (down 392.0% YoY), and the FY2025 annual result was 5.34%, down 7605.0% from the prior year.
- Net Margin was 23.12% for Q1 2020 at Grifols, up from 17.91% in the prior quarter.
- Over five years, Net Margin peaked at 36.05% in Q1 2016 and troughed at 7.14% in Q4 2016.
- Average Net Margin over 5 years is 18.58%, with a median of 17.91% recorded in 2019.
- Year-over-year, Net Margin jumped 2191 bps in 2016 and slumped 1414 bps in 2017.
- Over 5 years, Net Margin stood at 7.14% in 2016, then jumped by 223 bps to 23.06% in 2017, then dropped by 7 bps to 21.54% in 2018, then retreated by 17 bps to 17.91% in 2019, then rose by 29 bps to 23.12% in 2020.
- Per Business Quant data, the three most recent Net Margin figures were 23.12% in Q1 2020, 17.91% in Q4 2019, and 14.82% in Q1 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 37.36% |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 21.76% |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 4.65% |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | 329.02% |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | -25.84% |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 21.11% |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 29.04% |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | -0.56% |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Grifols | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 17.91% |
| Dec 31, 2018 | 21.54% |
| Dec 31, 2017 | 23.06% |
| Dec 31, 2016 | 7.14% |
| Dec 31, 2015 | 12.28% |
| Sep 30, 2015 | 14.43% |
| Jun 30, 2015 | 0.01% |
| Dec 31, 2014 | -13.90% |
| Sep 30, 2014 | 13.80% |
| Jun 30, 2014 | 0.00% |
| Mar 31, 2014 | 15.16% |
| Dec 31, 2013 | -38.41% |
| Sep 30, 2013 | 12.65% |
| Jun 30, 2013 | 13.17% |
| Mar 31, 2013 | 13.31% |
| Dec 31, 2012 | -29.84% |
| Sep 30, 2012 | 9.93% |
| Jun 30, 2012 | 10.15% |
| Mar 31, 2012 | 10.13% |
| Dec 31, 2011 | -7.42% |